Cargando…
Cisplatin resistance by induction of aldo-keto reductase family 1 member C2 in human bladder cancer cells
Cisplatin is currently the most effective anti-tumor agent available against bladder cancer. To clarify the mechanism underlying cisplatin resistance in bladder cancer, the present study examined the role of the aldo-keto reductase family 1 member C2 (AKR1C2) protein on chemoresistance using a human...
Autores principales: | SHIRATO, AKITOMI, KIKUGAWA, TADAHIKO, MIURA, NORIYOSHI, TANJI, NOZOMU, TAKEMORI, NOBUAKI, HIGASHIYAMA, SHIGEKI, YOKOYAMA, MASAYOSHI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919892/ https://www.ncbi.nlm.nih.gov/pubmed/24527071 http://dx.doi.org/10.3892/ol.2013.1768 |
Ejemplares similares
-
Aldo-Keto Reductases in the Eye
por: Huang, Shun Ping, et al.
Publicado: (2010) -
Regulation of Aldo–Keto Reductases in Human Diseases
por: Chen, Wei-Dong, et al.
Publicado: (2012) -
Aldo-keto reductase (AKR) superfamily: Genomics and annotation
por: Mindnich, Rebekka D, et al.
Publicado: (2009) -
Aldo-Keto Reductases 1B in Endocrinology and Metabolism
por: Pastel, Emilie, et al.
Publicado: (2012) -
Acceleration of an aldo-keto reductase by minimal loop engineering
por: Krump, C., et al.
Publicado: (2014)